Peripheral neuropathy pain can be excruciating and life-altering. What many patients don’t realize is that their mysterious nerve pain may actually be connected to an underlying Lyme disease infection ...

If you have peripheral neuropathy, consider treating your body to a regular yoga practice. Peripheral neuropathy is a form of nerve damage that causes tingling, numbness, sensitivity to touch, and ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it. Waldenström macroglobulinemia (WM) is a type of ...

Poster Title: "Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model" Building on Bold Therapeutics' Phase ...

Chemotherapy-induced peripheral neuropathy is a potentially debilitating adverse effect of cancer therapy that can lead to delay, reduction, or discontinuation of cancer treatment. Population-based ...

Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with chronic pain conditions, including peripheral neuropathy. You treat a lot of ...

Diabetic neuropathy refers to nerve damage due to diabetes. When it affects the feet, healthcare professionals call it peripheral neuropathy. It usually affects both feet at the same time, as well as ...

Peripheral neuropathy is a complex and often debilitating condition that affects millions of people worldwide. Research estimates around 10% of the general population experiences some form of ...

Please provide your email address to receive an email when new articles are posted on . The odds of developing dry eye disease were nearly four-times higher in patients with moderate to severe ...

Age-related hearing loss and peripheral neuropathy in older adults reduce longevity both directly and indirectly by affecting balance and gait. Researchers analyzed 793 older adults recruited from ...

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, ...